Malaria Vaccines: Clinical Trials

6 trials of Malaria Vaccines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 unknown, 1 active not recruiting, 1 terminated. 3 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Terminated 1
Phase 22Active not recruiting 1, Not yet recruiting 1
Not applicable1Not yet recruiting 1

Follow Malaria Vaccines: new trials by email Literature Review of Malaria Vaccines trials Research Report on Malaria Vaccines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )
Malaria Vaccine, HBV vaccine - Plasmodium Vivax Infection, Malaria Vaccine
Phase 2Not yet recruitingUniversity of Oxford362027-01-012026-03-24
The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency
Iron syrup, Multivitamin syrup, R21-Matrix/M Vaccine (malaria vaccine) - Iron Deficiencies
Not applicableNot yet recruitingNicole Stoffel3242026-01-052025-12-26
Infant Malaria Vaccine Schedule Optimization
R21 Matrix-M (R21/MM) Malaria Vaccine, Placebo, Hexavalent Vaccine - Malaria Vaccines, Malaria (Plasmodium Falciparum)
Phase 2Active not recruitingPATH9752025-05-302026-09-29
Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
GMZ2 (malaria vaccine), GMZ2 malaria vaccine, Verorab vaccine - Malaria
Phase 1UnknownAfrican Malaria Network Trust402007-06-012008-04-03
GMZ2-Aluminum Hydroxide Phase I, Tübingen
GMZ2 (GLURP + MSP3 Hybrid) (malaria vaccine) - Malaria
Phase 1UnknownEuropean Vaccine Initiative302006-10-012007-08-10
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
Virosome-formulated synthetic peptides (malaria vaccine) - Falciparum Malaria
Phase 1TerminatedSwiss Tropical & Public Health Institute462003-11-012006-11-16

Conditions studied

Malaria (4)  ·  Malaria, Falciparum (2)  ·  Iron Deficiencies (1)  ·  Measles (1)

Sponsors

African Malaria Network Trust (1)  ·  European Vaccine Initiative (1)  ·  Nicole Stoffel (1)  ·  PATH (1)  ·  Swiss Tropical & Public Health Institute (1)  ·  University of Oxford (1)

Countries

Burkina Faso (1)  ·  Gabon (1)  ·  Germany (1)  ·  Thailand (1)

Top investigators

Peter Kremsner, MD, PhD (2)  ·  Blaise Genton, MD PhD (1)  ·  Jurgen Knobloch, MD (1)  ·  Nicholas Day, MD (1)  ·  Nicole Stoffel, PhD (1)

Results publications

PMID 17925866, PMID 18060072